Focus: Salix Pharmaceuticals is a specialty pharmaceutical company focused on gastroenterological and neurological therapies, headquartered in Bridgewater, NJ. The company operates as a commercial-stage specialist with a concentrated portfolio of small-molecule products.
Profile data last refreshed 20h ago · AI intelligence enriched 1w ago
No open roles listed right now. Follow Salix Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Core asset generating 83% of company revenue with 12+ years of patent protection; guanylate cyclase activator for GI motility.
Help build intelligence for Salix Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Salix Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Proton pump inhibitor approaching loss of exclusivity; minimal revenue contribution.
Laxative formulation for colonoscopy prep; two-dose regimen with mid-2030s LOE.
5-ASA anti-inflammatory for IBD; first patent cliff risk by May 2030.
Peripheral mu-opioid antagonist for OIC; LOE 2031, addresses opioid side effects without CNS effects.
Fibrate PPAR-alpha agonist; approaching generic competition with minimal current revenue.
Corticosteroid for IBD; colonic-targeted formulation with LOE September 2031.
3 discontinued, 1 duplicate formulations not shown
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo